This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Market News

Market news

  • News Troubleshooting from a tablet manufacturer’s perspective

    I Holland to host a solutions-led seminar focusing on resolving tablet compression issues.
  • News Rentschler Biotechnologie transitions into a European corporation called Rentschler Biopharma SE

    This legal form of company strengthens its position as a full-service CDMO and ensures its place as an industry leader.
  • News Boosting capabilities through collaboration

    CDMO, Micro-Sphere partners with German machine manufacturer Harro Höfliger for the latest step in its 21 million CHF (€19 million) investment into its facility in Switzerland.
  • News Merck invests €35 million in its Italian biotech manufacturing site of Bari

    New production line for the aseptic filling of biotech medicines under isolator.
  • News Tubilux selects TraceLink to achieve EU FMD Compliance

    By leveraging TraceLink’s network tenant architecture, Tubilux can eliminate the complexity and costs associated with point-to-point integrations for its EU pharmaceutical manufacturing customers.
  • News Construction starts for Sartorius' new Cell Culture Technology Centre

    The 30-million-euro investment will accommodate the growing needs of customers.
  • News PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials

    Use of PnuVax’s unique patented conjugation platform technology to produce the vaccine is expected to speed up biomanufacturing and increase yield for a greatly reduced per-dose cost.
  • News SGS partnership helps clients to beat pharmaceutical counterfeiting

    Partnership will provide SGS clients with a unique additional analytical service that uses cutting-edge technology to verify product authenticity, process authenticity and product/process infringement.
  • News Brammer Bio expands "much needed" cell and gene therapy capacity

    CDMO partners with Pall Life Sciences to deliver an end-to-end single-use platform solution from upstream to downstream.
  • News Quanticate doubles its footprint in India

    New center of excellence to support further development of collaborative, long-term partnerships with leading pharmaceutical companies.
  • News Domestic companies predict a 16% growth in the South Korean pharma market

    CPHI onsite survey highlights emerging trends in 2017 for South Korean pharma.
  • News Highly potent APIs - can your CMO handle them?

    The importance of ensuring a facility has the right capabilities when selecting a CMO to handle high potency ingredients.
  • News CPHI Worldwide Pharma Awards finalists unveiled

    Largest ever CPHI Pharma Awards receives 200+ entries, with judges evaluating over 250,000 words.
  • News Ardena acquisition will support sponsors with bioanalytical and drug discovery services

    CDMO on target to become a one-source contract partner for early-phase development.
  • News Centauri scoops up to £945K award to develop innovative antibiotics

    Project will use the company's Alphamer technology, which is based on 'programmable immunity' in which chemically synthesized molecules redirect naturally occurring antibodies to selected pathogens to fight the infection.
  • News Lyophilization questions answered in real time

    Two free webinars - 'Lyophilizer Sublimation and Heat Transfer Modelling' and 'The Freezing Stage in Freeze Drying: Fundamental Concepts 2.0' - delivered by industry experts.
  • News Emulsifying, encapsulating and eliminating in one go

    Ear health and hygiene with a novel twist.
  • News Building on shaky foundations? 'No way' says Sartorius

    Award-winning building protected by special construction against vibration and temperature fluctuations.
  • News New service delivers streamlined pathway for Phase I trial milestones

    Whether you're a small, virtual firm or Big Pharma, Recipharm Pathway to Clinic can remove the complexity out of first in human projects.
  • News FDA warns Pfizer company about cGMP violations associated with the manufacture of EpiPen

    Warning letter cites Meridian Medical Technologies' failure to thoroughly investigate multiple serious component and product failures of EpiPen products.
  • News Research reveals costly implementation is the biggest barrier to serialization compliance

    The time it takes to develop a solution has been gravely underestimated by a large part of the industry.
  • News Merck prepares strategic options for the Consumer Health business

    Important step in executing science and technology focused strategy.
  • News Novo Nordisk settles US federal investigation of marketing practices

    In connection with the $60 million settlement, the company has also resolved several private whistle-blower cases related to the government's investigation.
  • News Eli Lilly streamline operation to affect 3500 workers

    Majority of the positions eliminated expected to come from a US voluntary early retirement program.
  • News Vectura and Pulmatrix sign branded generic tiotropium bromide development agreement

    Major new tiotropium bromide DPI development programme accelerated through licensing of Pulmatrix technology.
  • News Life-extending pancreatic cancer medicine recommended by NICE in final guidance

    The pivotal Phase III study demonstrated that treatment with Abraxane in combination with gemcitabine can offer patients a median overall survival improvement of 1.8 months.
  • News Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in immuno-oncology

    Rigontec’s immuno-oncology approach of engaging the innate immune system to safely eliminate cancer cells complements Merck's strategy and current pipeline.
  • News Novartis CEO, Joseph Jimenez, to retire from Novartis in 2018

    Vasant Narasimhan appointed CEO, effective 1February 2018.
  • News SGS Clinical Research strengthens its consultancy service to accelerate drugs through early phase development

    Company consolidates its consultancy portfolio into a single, comprehensive offering.
  • News Catalent signs commercial manufacturing agreement with US WorldMeds for lofexidine

    Lofexidine is an investigational drug under development to mitigate symptoms associated with opioid withdrawal.
  • News Clintec expands UK headquarters and is presented with Queens Award for Enterprise – International Trade

    Company's additional 4327-sq ft floor at Clintec’s Glasgow-based headquarters forms a fully dedicated centre of excellence for clinical research and quality assurance capabilities.
  • News Takeda disappointed as NICE issue second negative draft decision for ixazomib

    Company says it is determined to work collaboratively to find a solution.
  • News Janssen enters exclusive distribution agreement for Invokana and Vokanamet

    Distribution agreement covers countries in the EEA and Switzerland.
  • News 3SBio accelerates expansion of its global biologics platform

    The Chinese biopharmaceutical company acquires the Canadian biomanufacturing business of Therapure.
  • News Merck successfully closes biosimilars transaction

    Step towards strategic alignment of R&D resources to Healthcare priorities.
  • News FDA approves Pfizer's Mylotarg for treatment of AML

    Only approved antibody-drug conjugate for newly diagnosed and relapsed or refractory CD33-positive AML.
  • News Xeno-free cell culture medium for regenerative medicine research

    StemFit Basic02 offers superior and stable growth performance, high colony forming efficiency and robust scalable cell expansion.
  • News Thermo Fisher Scientific completes acquisition of Patheon

    Patheon's CDMO capabilities coupled with Thermo's clinical trials services and bioproduction technologies expected to make Thermo and "even stronger partner" for its pharmaceutical and biotech customers.
  • News AstraZeneca and Takeda collaborate to develop and commercialise MEDI1341 for Parkinson’s disease

    MEDI1341 has the potential to achieve a better efficacy and safety profile than other alpha-synuclein antibodies.
  • News Cambrex invests in new analytical development and method validation laboratory at its High Point, NC Facility

    Expansion comes as a result of increased industry demand to better understand and characterize APIs and process intermediates at the clinical stage.
  • News Novartis receives first ever FDA approval for a CAR-T cell therapy

    Kymriah approvaed for children and young adults with B-cell ALL that is refractory or has relapsed at least twice.
  • News FDA approves new antibacterial drug

    First carbapenem-based combination product – combination of meropenem with a new class of beta-lactamase inhibitor.
  • News Fire at Ashland facility suspends production of BDO, THF and formaldehyde

    Volume expected to remain somewhat constrained into the first quarter of fiscal 2018.
  • News Berg and AstraZeneca collaborate to identify new therapeutic targets to treat neurological disorders

    Collaboration to focus on a disease target in Parkinson's disease with Berg's Interrogative Biology technology.
  • News Sanofi completes the acquisition of Protein Sciences

    An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio.
  • News Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

    Biogen becomes the first company with approved biosimilars for the three most prescribed anti-TNF biologic treatments in Europe.
  • News Class action lawsuit filed on behalf of investors in Teva

    Complaint alleges Teva failed to disclose the poor performance of its US generics business and the subsequent goodwill impairment charge stemming from the company’s purchase of Actavis Generics.
  • News Boehringer Ingelheim receives FDA approval for its Humira biosimilar

    Cyltezo approved for the treatment of multiple chronic inflammatory diseases.
  • News MedPharm strengthens management on back of US success

    Appointments come as global leader in contract topical and transdermal pharmaceutical development benefits from increased revenues.
  • News Otsuka and Mylan sign license agreement to commercialize delamanid for MDR-TB in high-burden countries

    Mylan granted an exclusive license by Otsuka to prioritize access to Deltyba in South Africa and India.
  • News Charles River Laboratories acquires Brains On-Line

    Establishes Charles River as a premier source for CNS contract research services.
  • News Bavarian Nordic closes transaction with Janssen Pharmaceuticals

    Collaboration grants Janssen the exclusive rights to Bavarian Nordic’s MVA-BN technology for two additional programs, targeting vaccines against hepatitis B virus and the human immunodeficiency virus.
  • News Amgen and Humana partner for improved health outcomes and efficiency

    Partnership to target multiple serious diseases using real world data studies.
  • News Spray drying specialist to invest €19 million in GMP facility expansion

    Investment is in response to increased market for spray drying and capsule filling for dry powder inhalers.
  • News Oak Therapeutics completes critical milestone in Phase I to develop oral dissolvable strip for TB

    Comapny has created a novel formulation to produce a product prototype containing 300 mg of Isoniazid, that is both rapidly dissolving and mucoadhesive.
  • News Oxford Genetics secures £7.5 million investment

    Investment will fund a new office in Boston, US, an extension of its UK facility at the Oxford Science Park, and R&D capabilities to increase its intellectual property portfolio.
  • News Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models

    Models will be used in AstraZeneca's oncology R&D programs in breast and lung cancer.
  • News RedHill Biopharma announces US commercialization agreement for FDA-approved GI product

    Esomeprazole Strontium DR capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor, indicated for adults for the treatment of gastroesophageal reflux disease and other gastrointestinal conditions.
  • News Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector

    Mylan will reclassify EpiPen Auto-Injector for purposes of the Medicaid Drug Rebate Program and pay the rebate applicable to innovator products effective as of 1 April 2017.
  • News Pfizer to adopt Orion cloud platform for computational chemistry

    Orion's workflow tools will help Pfizer's efforts to deliver potential breakthrough therapies for patients.
  • News Hikma announces new licensing agreement with Takeda for products in the MENA

    Hikma granted the exclusive rights to manufacture and commercialise three of Takeda’s leading primary care product families.
  • News Evotec completes acquisition of Aptuit

    Employees and capabilities will be integrated into Evotec's global drug discovery group to maximise commercial synergies.
  • News Vectura signs global development agreement with Dynavax

    Agreement convers the clinical application of Vectura's proprietary smart nebuliser technology to deliver Dynavax's investigational immunotherapeutic agent to lung cancer patients.
  • News Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity

    Novo Nordisk will have an option to license the FGF1 program upon achievement of certain research milestones.
  • News Abcam and TTP Labtech collaborate to develop sol-R reagent kits

    Assay-ready kits will incorporate fully-validated, industry-leading recombinant antibody technology for high throughput research.
  • News The Great Hall of China: double digit growth at CPHI China

    The Asian pharma event surpasses 55,000 visits with more than 10,000 overseas visits.
  • News Bespoke filtration equipment enables pharma manufacturer to fulfil contract

    Major pharma manufacturer delivers critical drugs to a leading children's hospital.
  • News Cambridge Epigenetix and NuGEN Technologies combine leading technologies in epigenetics research

    Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl technology for oxidative bisulfite sequencing with Targeted Methylation and NuGEN Ovation Methyl-Seq systems.
  • News Fortress Biotech forms new subsidiary, Aevitas Therapeutics

    Subsidiary to develop novel AAV gene therapy treatments for complement-mediated.
  • News Tyme Technologies announces the issuance of two new platform patents

    The two patents represent the next generation of SM-88, joining tyrosine and melanin into a potentially more potent combination.
  • News FDA approves liposome-encapsulated combination of daunorubicin-cytarabine for adults with AML

    Vyxeos represents the first new chemotherapy advance in more than 40 years for these adults with AML.
  • News Mylan launches Avonza in India

    Company is first to offer innovative, reduced-dose HIV treatment in India.
  • News CPHI India Report identifies two-tier manufacturing market and predicts increased acquisitions

    CDSCO certification has improved international repute of India, but domestic companies call for urgent Government support to invest in API facilities.
  • News SK Capital agrees to acquire Perrigo API business

    Transaction is expected to close during Q4 2017, before which a new trade name will be selected for the Business.
  • News Major progress in next generation medicines initiative

    Juniper Pharma Services now has CrystecPharma’s supercritical fluid technology platform on-site.
  • News TraceLink breaks new record for highest quarterly sales bookings in Q2 2017

    Company also becomes the first solution provider to achieve 100 pharmaceutical and contract manufacturers live and ready for serialization.
  • News Biotech sector will drive biggest advancements in decades on cancer treatments

    Small nimble biotechs to introduce a ‘golden age’ of next generation therapies such as CAR-T, combination therapies, innate immune system approaches, and newer check-point inhibitors.
  • News SGS expands and increases capacity by 50% at its Lincolnshire, IL facility

    Investment will increase the company's flexibility in meeting both existing and future customer demands.
  • News Cambrex invests $24 million in new HPAPI manufacturing capacity at its Charles City, Iowa facility

    Project also includes reconfigure the existing small-scale manufacturing area providing a single high-containment building to support early-stage development and manufacturing.
  • News EIB backs German cancer therapy developer MagForce with up to EUR 35m

    The company's NanoTherm therapy makes it possible to combat the tumour from within, while sparing surrounding healthy tissue.
  • News Sanner invests in Bensheim production facility

    14 new injection-molding machines and significant increase in efficiency and energy savings.
  • News Impax announces settlement of contract litigation on Opana ER CII Extended-Release tablets

    Contract dispute relates to an agreement entered into among Endo International, Penwest Pharmaceuticals and Impax.
  • News New controlled nucleation resource center

    SP Scientifc's ControLyo Central is a suite of online resources to help freeze dried parenterals manufacturers.
  • News Insanitary conditions bring Isomeric Pharmacy Solutions to a halt

    Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions.
  • News AbbVie's Mavyret receives FDA approval for the treatment of chronic hepatitis C

    FDA approval is supported by an overall 98% cure rate in patients who received the recommended duration of treatment .
  • News Captek Softgel International acquires J+D Labs

    J+D Labs’ extensive experience manufacturing a wide-range of softgels, specialized tablets, capsules, and powder formulations complements Captek’s offerings.
  • News NICE approves Abraxane for pancreatic cancer

    Life-extending pancreatic cancer medicine to be made available immediately on the NHS.
  • News Lonza acquires Micro-Macinazione to create the leader in micronization capacity and capabilities

    Bolt-on acquisition adds value to other areas of Lonza’ business, including Health & Nutrition ingredients and excipients.
  • News The new KTP 590X rotary press sharpens Romaco Kilian’s effervescents profile

    Romaco will additionally show Innojet process technology and Kilian services at POWTECH.
  • News BMS to acquire IFM Therapeutics to strengthen oncology pipeline focus on innate immunity

    Gains full rights to IFM’s preclinical STING and NLRP3 agonist programs focused on enhancing the innate immune response for treating cancer.
  • News Biopharma stages a strong recovery over the first half even as M&A deals disappoint

    EP Vantage releases half-year reviews of pharma & biotech and medtech performance.
  • News Baxter completes acquisition of Claris Injectables, expanding generic injectable medicines portfolio

    Baxter plans to invest in further increasing Claris Injectables’ capacity and capabilities, including adding new aseptic manufacturing and lyophilization.
  • News TraceLink expands offering with ROC IT Solutions acquisition

    Company can now offer solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products.
  • News Cherwell publishes Cleanroom Decontamination Guide

    Guide aims to help the operator understand the complex protocols and heavily regulated procedures associated with pharmaceutical cleanrooms.
  • News STA Pharmaceutical merges with WuXi¹s Pharmaceutical Development Services Division

    The merger enables STA to advance NCEs from pre-clinical stage to New Drug Application and to market faster and more efficiently for pharma and biotech customers.
  • News BMS and Clovis Oncology announce a broad clinical collaboration to evaluate combination of Opdivo and Rubraca

    Pivotal Phase III trials planned for 2017 will evaluate Rubraca + Opdivo, Rubraca as monotherapy, and Opdivo as monotherapy in first line maintenance treatment for advanced ovarian and advanced triple-negative breast cancers.
  • News Arch Biopartners' GMP manufacturing of AB569 on schedule

    Dalton Pharma Services is preparing glass vials in three varying dose formulations for the clinical kits needed to support the Phase I safety trial for AB569 at the CVAMC later this year.
  • News AstraZeneca and Merck establish oncology collaboration

    Collaboration aims to maximize the potential of PARP and MEK inhibitors in combination with PD-L1/PD-1 medicines, based on growing scientific evidence that these combinations offer new potential for the treatment of a range of tumor types.
  • News Torbay Pharmaceuticals opens new £26 million pharmaceutical manufacturing unit

    The new facilities enable to company to further grow and flourish.